Predictive biomarkers for molecular pathology in lung cancer

被引：6
|
作者：
Pisapia, Pasquale [1 ]
Pepe, Francesco [1 ]
Troncone, Giancarlo [1 ]
Malapelle, Umberto [1 ]
机构：
[1] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
来源：
BIOMARKERS IN MEDICINE | 2020年 / 14卷 / 04期
关键词：
ALK; EGFR; liquid biopsy; molecular oncology; molecular pathology; NGS; novel biomarkers; NSCLC; PD-L1; ROS1; DABRAFENIB PLUS TRAMETINIB; OPEN-LABEL; TESTING GUIDELINE; CHEMOTHERAPY; CRIZOTINIB; INHIBITORS; MUTATIONS; PHASE-2; IMMUNOHISTOCHEMISTRY; ASSOCIATION;
D O I：
10.2217/bmm-2019-0490
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：253 / 256
页数：4
相关论文
共 50 条
  • [1] Molecular Pathology of Lung Cancer
    Roy-Chowdhuri, Sinchita
    CLINICS IN LABORATORY MEDICINE, 2024, 44 (02) : 137 - 147
  • [2] Predictive molecular pathology of lung cancer in Germany with focus on gene fusion testing: Methods and quality assurance
    Siemanowski, Janna
    Heydt, Carina
    Merkelbach-Bruse, Sabine
    CANCER CYTOPATHOLOGY, 2020, 128 (09) : 611 - 621
  • [3] Driver mutations as predictive biomarkers in lung cancer
    Girard, Nicolas
    CURRENT PULMONOLOGY REPORTS, 2012, 1 (01) : 21 - 29
  • [4] Molecular and Clinical Analysis of Predictive Biomarkers in Non-Small-Cell Lung Cancer
    Passaro, A.
    Palazzo, A.
    Trenta, P.
    Mancini, M. L.
    Morano, F.
    Cortesi, E.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (22) : 3689 - 3700
  • [5] Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
    Mino-Kenudson, Mari
    Schalper, Kurt
    Cooper, Wendy
    Dacic, Sanja
    Hirsch, Fred R.
    Jain, Deepali
    Lopez-Rios, Fernando
    Tsao, Ming Sound
    Yatabe, Yasushi
    Beasley, Mary Beth
    Yu, Hui
    Sholl, Lynette M.
    Brambilla, Elizabeth
    Chou, Teh-Ying
    Connolly, Casey
    Wistuba, Ignacio
    Kerr, Keith M.
    Lantuejoul, Sylvie
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (12) : 1335 - 1354
  • [6] Unravelling the diagnostic pathology and molecular biomarkers in lung cancer
    Charpidou, Andriani
    Hardavella, Georgia
    Boutsikou, Efimia
    Panagiotou, Emmanouil
    Simsek, Gokcen Omeroglu
    Verbeke, Koen
    Xhemalaj, Daniela
    Domaga, Joanna
    BREATHE, 2024, 20 (02)
  • [7] Advance of theragnosis biomarkers in lung cancer: from clinical to molecular pathology and biology
    Alidousty, Christina
    Baar, Till
    Heydt, Carina
    Wagener-Ryczek, Svenja
    Kron, Anna
    Wolf, Juergen
    Buettner, Reinhard
    Schultheis, Anne Maria
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S3 - S8
  • [8] Considerations for standardizing predictive molecular pathology for cancer prognosis
    Fiorentino, Michelangelo
    Scarpelli, Marina
    Lopez-Beltran, Antonio
    Cheng, Liang
    Montironi, Rodolfo
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (01) : 47 - 55
  • [9] Immunohistochemistry-based predictive biomarkers for lung cancer
    Schildhaus, Hans-Ulrich
    PATHOLOGE, 2020, 41 (01): : 21 - 31
  • [10] Molecular lung cancer: How targeted therapies and personalized medicine are re-defining cancer care
    Quinn, Zachary L.
    Barta, Julie A.
    Johnson, Jennifer M.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 364 (04) : 371 - 378
12345